You are here

Activity

Activity
  • Toney Padgett posted an update 4 months, 1 week ago

    Pepine, “Nicardipine, a new calcium channel blocker: role for vascular selectivity” Clin. Cardiol. vol. 12, no. 5, pp. 240-246, May 1989. [145] G. Kojda, W. Klaus, G. Werner, U. Fricke, “The influence of 3-ester side chain variation around the cardiovascular profile of nitrendipine in porcine isolated trabeculae and coronary arteries” Naunyn Schmiedebergs Arch. Pharmacol. vol. 344, no.4, pp. 488-494, 1991. [146] R. Bayer, D. Kalusche, R. Kaufmann, R. Mannhold, “Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects in the optical isomers on transmembrane action potentials” Naunyn Schmiedebergs Arch .Pharmacol. vol. 290, no. 1, pp. 81-97, 1975.[147] R. Towart, E. Wehinger, H. Meyer, “Effects of unsymmetrical ester substituted 1,4-dihydropyridine derivatives and their optical isomers on contraction of smooth muscle” Naunyn Schmiedebergs Arch Pharmacol vol. 317, no. two, pp. 183-185, Sep. 1981.[148] T. Shibanuma, M. Iwanani, K. Okuda, T. Takenaka, and M. Murakami, “Synthesis of optically active 2-(N-benzyl-N-methylamino)ethyl methyl 2,6dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5dicarboxylate (Nicardipine)” Chem. Pharm. Bull. vol. 28, no. 9, pp. 2809-2812, Sep. 1980. [149] J.E. Arrowsmith, S.F. Campbell, P.E. Cross, J.K. Stubbs, R.A. Burges, D.G. Gardiner, K.J. Blackburn, 1940-0640-8-15 “Long-acting dihydropyridine calcium antagonists. 1. 2Alkoxymethyl derivatives incorporating SCR7MedChemExpress SCR7 simple substituents” J. Med. Chem. vol. 29, no. 9, pp. 1696-1702, 1986. [150] R. Towart, E. Wehinger, H. Meyer, S. Kazda, “The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle” Arzneimittelforschung vol. 32, no. 4, pp. 338-346, 1982. [151] M. Kajino, Y. Wada, Y. Nagai, A. Nagaoka, K. Meguro, “Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5pyridinedicarboxylate (manidipine) dihydrochloride” Chem. Pharm. Bull. vol. 37, no. 8, pp. 2225-2228, Aug. 1989. [152] O. Inagaki, M. Asano, T. Takenaka, “In vitro and in vivo vasodilatory activity of barnidipine and its enantiomers” Biol. Pharm. Bull. vol. 22, no. 2, pp. 151156, Feb. 1999. [153] G. Mikus, V. Mast, D. Ratge, H. Wisser, M. Eichelbaum, “Stereoselectivity in cardiovascular and biochemical action of calcium antagonists: research with all the enantiomers of the dihydropyridine nitrendipine” Clin. Pharmacol. Ther. vol. 57, no. 1, pp. 52-61, Jan. 1995. [154] P.A. Soons, A.F. Cohen, D.D. Breimer, “Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effectrelationships of racemic drugs and enantiomers” Eur. J. Clin. Pharmacol. vol. 44, no. two, pp. 113-120, 1993. [155] R.P. Hof, A. Hof, U.T. Ruegg, N.S. Cook, A. Vogel, “Stereoselectivity in the calcium channel: various profiles of hemodynamic activity in the enantiomers of fnins.2013.00251 the dihydropyridine derivative PN 200-110″ J. Cardiovasc. Pharmacol. vol. eight, no. two, pp. 221-226, Apr. 1986. [156] F.T. van Amsterdam, J. Zaagsma, “Stereoisomers of calcium antagonists discriminate amongst coronary vascular and myocardial sites” Naunyn Schmiedebergs Arch. Pharmacol. vol. 337, no. 2, pp. 213219, Feb. 1988. [157] G. Marciniak, A. Delgado, G. Leclerc, J. Velly, N. Decker, J. Schwartz, “New 1,4-dihydropyridine derivatives combining calcium antagonism and alphaadrenolytic properties” J. Med. Chem. vol. 32, no.

Skip to toolbar